Upstate New York Pharmacy Fined After Drugs Disappear
An Upstate New York pharmacy agreed to a large fine after a large number of drugs went missing.
On Thursday, United States Attorney Carla B. Freedman and Special Agent in Charge Frank A. Tarentino III, U.S. Drug Enforcement Administration (DEA), New York Division announced a settlement with an Upstate New York pharmacy.
Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations
Greene Pharma LLC, Greene Medical Arts Pharmacy, a pharmacy in Catskill, New York, agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act, officials say.
Read More: ‘Eerie,’ Haunted Upstate New York Hotel Destroyed By Fire
"During a January 2022 inspection and controlled substance audit, DEA determined that Greene Pharma failed to keep adequate records pertaining to the receipt and disposition of various controlled substances, including oxycodone, hydrocodone, alprazolam, methylphenidate, and buprenorphine," officials said in a press release.
Greene County, New York Pharmacy Fined
The pharmacy then performed a self-audit of its controlled substance records and couldn't account for 200 oxycodone tablets, 144 buprenorphine films, and 2 buprenorphine tablets.
Pharmacy officials believe the drugs were stolen by an employee who wasn't properly screened before being hired, officials say.
"DEA also determined that Greene Pharma failed to maintain records required by the CSA, including pseudoephedrine logs and Controlled Substance Ordering System (CSOS) electronic order forms. This settlement resolves the United States allegations that Greene Pharma caused controlled substances to be distributed without a valid prescription and failed to keep records required by the CSA," officials add.
For all the news that the Hudson Valley is sharing make sure to follow Hudson Valley Post on Facebook, download the Hudson Valley Post Mobile App and sign up for the Hudson Valley Post Newsletter.
Greene Pharma also agreed to perform employee background checks in the future and maintain complete and accurate records pertaining to the receipt and sale of controlled substances.